Correction: TERT promoter mutations and other prognostic factors in patients with advanced urothelial carcinoma treated with an immune checkpoint inhibitor

Guardado en:
Detalles Bibliográficos
Formato: article
Lenguaje:EN
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://doaj.org/article/a16ba26abc8c4df287b0a45572f64afe
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a16ba26abc8c4df287b0a45572f64afe
record_format dspace
spelling oai:doaj.org-article:a16ba26abc8c4df287b0a45572f64afe2021-11-06T15:30:05ZCorrection: TERT promoter mutations and other prognostic factors in patients with advanced urothelial carcinoma treated with an immune checkpoint inhibitor10.1136/jitc-2020-002127corr12051-1426https://doaj.org/article/a16ba26abc8c4df287b0a45572f64afe2021-09-01T00:00:00Zhttps://jitc.bmj.com/content/9/9/e002127corr1.fullhttps://doaj.org/toc/2051-1426BMJ Publishing GrouparticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENJournal for ImmunoTherapy of Cancer, Vol 9, Iss 9 (2021)
institution DOAJ
collection DOAJ
language EN
topic Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Correction: TERT promoter mutations and other prognostic factors in patients with advanced urothelial carcinoma treated with an immune checkpoint inhibitor
format article
title Correction: TERT promoter mutations and other prognostic factors in patients with advanced urothelial carcinoma treated with an immune checkpoint inhibitor
title_short Correction: TERT promoter mutations and other prognostic factors in patients with advanced urothelial carcinoma treated with an immune checkpoint inhibitor
title_full Correction: TERT promoter mutations and other prognostic factors in patients with advanced urothelial carcinoma treated with an immune checkpoint inhibitor
title_fullStr Correction: TERT promoter mutations and other prognostic factors in patients with advanced urothelial carcinoma treated with an immune checkpoint inhibitor
title_full_unstemmed Correction: TERT promoter mutations and other prognostic factors in patients with advanced urothelial carcinoma treated with an immune checkpoint inhibitor
title_sort correction: tert promoter mutations and other prognostic factors in patients with advanced urothelial carcinoma treated with an immune checkpoint inhibitor
publisher BMJ Publishing Group
publishDate 2021
url https://doaj.org/article/a16ba26abc8c4df287b0a45572f64afe
_version_ 1718443686306512896